Pronuclear zygote score following intracytoplasmic injection of hyaluronan-bound spermatozoa: a prospective randomized study
Abstract
The aim of this study was to determine whether the early stages of embryo development, as assessed by the zygote score (Z-score), could be influenced by the injection of spermatozoa that had been preselected on the basis of their binding to hyaluronic acid (HA). A total of 407 sibling metaphase II oocytes, belonging to 44 different patients, were injected in a prospective randomized way, with either hyaluronic acid bound (HA+) or non-bound (HA−) spermatozoa. The fertilization rate (75–70%), the percentage of the different Z-scores (Z1: 22–24%, Z2: 22–22.5%, Z3: 44–45%, Z4: 12–8.5%), the mean score of the transferred embryos (3.76
±
1.29, 3.78
±
1.1) and the number of embryos at the 4-cell stage 45
h after injection (77–76%) were not different between the two groups. The ongoing pregnancy rate in this study (>20
weeks of gestation) was 36.4% per replacement, the implantation rate 28% and the twin pregnancy rate 44% (7/16). Although binding to HA did not apparently influence the Z-score, this agent continues to be used for the immobilization of spermatozoa prior to injection, on the basis that it is a natural product that can easily be metabolized by the oocyte via normal biological mechanisms.
Keywords: hyaluronic acid, ICSI, nucleogenesis, Z-score, pronucleus
To access this article, please choose from the options below
Marc Van den Bergh graduated in 1977 in clinical chemistry from the Technical High School in Bruges, Belgium. He worked at the Centre for Reproductive Medicine at the Dutch-Speaking Free University of Brussels between 1979 and 1989. He co-ordinated the IVF-laboratory team at the Fertility Clinic of the French-Speaking Free University of Brussels between 1990 and 2001. In 2001 he obtained a special Master’s degree in clinical embryology at the Danube University of Krems, Austria. He obtained his certification as Senior Clinical Embryologist in 2008 and since 2002 he has directed the IVF laboratory at the Kantonsspital Baden AG, Switzerland.Marc Van den Bergh
PII: S1472-6483(09)00086-8
doi:10.1016/j.rbmo.2009.09.022
© 2009 Reproductive Healthcare Ltd. Published by Elsevier Inc All rights reserved.
